(Updated - April 30, 2025 7:50 AM EDT)

Guggenheim analyst Vamil Divan lowered the price target on Merck (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE